ILC Granted Orphan Drug Designation in Europe for the Treatment of Osteosarcoma
October 08, 2013 08:32 ET
|
Eleison Pharmaceuticals LLC
ST. PETERSBURG, Fla., Oct. 8, 2013 (GLOBE NEWSWIRE) -- Eleison Pharmaceuticals LLC, a specialty pharmaceutical company developing life-saving therapeutics for rare cancers, announced the European...
Eleison Announces Initiation of Phase III Trial of Glufosfamide for Second-line Treatment of Pancreatic Cancer
October 07, 2013 16:00 ET
|
Eleison Pharmaceuticals LLC
ST. PETERSBURG Fla., Oct. 7, 2013 (GLOBE NEWSWIRE) -- Eleison Pharmaceuticals LLC, a specialty pharmaceutical company developing life-saving therapeutics for rare cancers, announced it has initiated a...